Amicus Therapeutics Inc. buy UBS Group AG
Start price
10.05.24
/
50%
€8.60
Target price
10.05.25
€17.63
Performance (%)
12.21%
Price
03.10.24
€9.45
Summary
This prediction is currently active. The prediction currently has a performance of 12.21%. This prediction currently runs until 10.05.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amicus Therapeutics Inc. | -0.526% | -0.526% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by UBS_Group_AG for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at UBS Group AG from $20.00 to $19.00. They now have a "buy" rating on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by UBS_Group_AG for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.00
02.03.23
02.03.23
€16.05
02.03.24
02.03.24
0.83%
03.03.24
03.03.24